• Go to navigation
  • Go to content
AstraZeneca

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca United States

Main navigation

  • Home
  • Our medicines
  • Responsibility
  • Community support
  • Help affording your medicines
  • Research & development
  • Health care professionals
  • HealthCare Foundation
  • Careers
  • About AstraZeneca US
    • Our company
    • AZ on the issues
    • Investors
    • Newsroom
      • All news
      • Corporate news
      • Financial news
      • Product news
      • Research news
      • Media resources
    • US Websites
    • Social media sites
    • Contact us

You are here

  • Home
  • About AstraZeneca US
  • Newsroom
  • News

The following shows headlines of news articles, starting from most recent.

  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next

Date

    • Jan 20, 2012
    • AstraZeneca, United Way of Delaware kick off statewide Youth Health Initiative  
    • Jan 19, 2012
    • Bristol-Myers Squibb and AstraZeneca receive complete response letter from U.S. Food and Drug Administration for dapagliflozin  
    • Dec 7, 2011
    • AstraZeneca to streamline US Sales Organization  
    • Dec 5, 2011
    • Despite trend of therapeutic substitution, survey data shows patients want their physician to be the ultimate decision maker on their Rx medications  
    • Nov 21, 2011
    • AstraZeneca appoints Fante, McCourt to leadership roles in Americas  
    • Nov 15, 2011
    • SATURN demonstrated effect of intensive statin treatment on reducing atherosclerosis  
    • Nov 7, 2011
    • BRILINTA™ (ticagrelor) receives additional Class I recommendation in new U.S. Guidelines from ACCF/AHA/SCAI for PCI  
    • Nov 7, 2011
    • New CRESTOR® (rosuvastatin calcium) Savings Card Program provides instant savings to patients  
    • Nov 3, 2011
    • BRILINTA™ (ticagrelor) receives Class I recommendation in new US Guidelines from the American College of Cardiology Foundation and the American Heart Association  
    • Oct 27, 2011
    • AstraZeneca PLC third quarter and nine months results 2011  
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next

Page tools

  • Print
  • Bookmark this page
  • Subscribe to RSS news feed

Stay connected with us

Stay connected with us on our social media sites

  • Stay connected with us on our social media sites

Legal notices

  • Legal Information
  • Privacy Statement
  • © AstraZeneca 2012